159
Views
6
CrossRef citations to date
0
Altmetric
Review

An approach to long-term sedative-hypnotic use

, , &
Pages 53-61 | Published online: 02 Apr 2012

References

  • Wake up America: a national sleep alert: report of the National Commission on Sleep Disorders ResearchWashington, DCDepartment of Health and Human Services; National Commission on Sleep Disorders Research (US)1993
  • MontplaisirJHawaRMollerHZopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statementHum Psychopharmacol2003181293812532313
  • MellingerGDBalterMBUhlenhuthEHInsomnia and its treatment. Prevalence and correlatesArch Gen Psychiatry19854232252322858188
  • FordDEKamerowDBEpidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?JAMA198926211147914842769898
  • ManabeKMatsuiTYamayaMSleep patterns and mortality among elderly patients in a geriatric hospitalGerontology200046631832211044786
  • MallonLBromanJEHettaJSleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish populationJ Intern Med2002251320721611886479
  • LeppavuoriAPohjasvaaraTVatajaRInsomnia in ischemic stroke patientsCerebrovas Dis20021429097
  • ChilcottLAShapiroCMThe socioeconomic impact of insomnia. An overviewPharmacoeconomics199610Suppl 111410163422
  • No authors listedInsomnia: assessment and management in primary care. National heart, lung, and blood institute working group on insomniaAm Fam Physician199959113029303810392587
  • Consensus conferenceDrugs and insomnia. The use of medications to promote sleepJAMA198425118241024146142971
  • CzeislerCARichardsonGSDetection and assessment of insomniaClin Ther19911366636791790541
  • TrajanovicNRadivojevicVKaushanskyYShapiroCMPositive sleep state misperception – a new concept of sleep misperceptionSleep Med20078211111817275407
  • SivertsenBOmvikSPallesenSCognitive behavorial therapy versus zopiclone for the treatment of chronic primary insomnia in older patientsJAMA2006295242851285816804151
  • LacksPMorinCRecent advances in the assessment and treatment of insomniaJ Consult Clin Psychol1992645865941506506
  • MorinCCombined therapeutics for insomnia: should our first approach be behavioral or pharmacological?Sleep Med20067Suppl 1S15S1916702028
  • MorinAKStrategies for treating chronic insomniaAm J Manag Care2006128 SupplS230S24516686593
  • EdingerJDKrystalADSub typing primary insomnia: is sleep state misperception a distinct clinical entity?Sleep Med Rev20037320321412927120
  • RiemannDThe hyperarousal model of insomnia: a review of the concept and its evidenceSleep Med Rev2010141193119481481
  • KennedySParikhSVShapiroCMDefeating DepressionThornhill, ONJoli Joco Publications, Inc.1998
  • OhayonMMShapiroCMKennedySHDifferentiating DSM-IV anxiety and depressive disorders in the general population: comorbidity and treatment consequencesCan J Psychiatry200045216617210742876
  • BencaRMDiagnosis and treatment of chronic insomnia: a reviewPsychiatr Serv200556333234315746509
  • FavaMMcCallWVKrystalAEszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorderBiol Psychiatry200659111052106016581036
  • ShenJMollerHJWangXMirtazapine a sedating antidepressant and improved driving safety in patients with major depressive disorder: a prospective randomized control trial of 28 patientsJ Clin Psychiatry200970337037719192466
  • LevitanRDShenJHJindaRLDriverHSKennedySHShapiroCMPreliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effectsJ Psychiatry Neurosci200025433734611022398
  • AndersonIMFerrierINBaldwinRCEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelinesJ Psychopharmacol200822434339618413657
  • BencaRMConsequences of insomnia and its therapiesJ Clin Psychiatry200162Suppl 10333811388589
  • KramerMHypnotic medication in the treatment of chronic insomnia: non nocere! Doesn’t anyone care?Sleep Med Rev20004652954112531035
  • McAndrewsMPKayumovLPhillipsonRShapiroCMSelf-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbanceHum Psychopharmacol200015858358712404610
  • McAndrewsMPWeissRTSandorPTaylorACarlenPLShapiroCMCognitive effects of long-term benzodiazepine use in older adultsHum Psychopharmacology20031815157
  • LuckiIRickelsKGellerAMChronic use of benzodiazepines and psychomotor and cognitive test performancePsychopharmacology (Berl)19868844264332871579
  • GolombokSMoodleyPLaderMCognitive impairment in long-term benzodiazepine usersPsychol Med19881823653742899898
  • HanlonJTHornerRDSchmaderKEBenzodiazepine use and cognitive function among community-dwelling elderlyClin Pharmacol Ther19986466846929871433
  • AdamKAdamsonLBrezinovaVHunterWMNitrazepam: lastingly effective but trouble on withdrawalBr Med J19761602515581560179657
  • OswaldIFrenchCAdamKGilhamJBenzodiazepine hypnotics remain effective for 24 weeksBr Med J (Clin Res Ed)19822846319860863
  • ScharfMBRothTVogelGWA multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomniaJ Clin Psychiatry19945551921998071269
  • ElieRRutherEFarrIEmilienGSalinasESleep latency is shortened during 4 weeks of treatment with zaleplon, a novel non benzodiazepine hypnotic. Zaleplon Clinical Study GroupJ Clin Psychiatry199960853654410485636
  • AllenRPMendelsJNevinsDBEfficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three monthsJ Clin Pharmacol198727107687752892863
  • WalshJKKrystalADAmatoDANightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitationsSleep200730895996817702264
  • RothTWalshJKKrystalAWesselTRoehrsTAAn evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomniaSleep Med20056648749516230048
  • PakesGEBrogdenRNHeelRCSpeightTMAveryGSTriazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomniaDrugs1981222811106114852
  • MaarekLCramerPAttaliPCoquelinJPMorselliPLThe safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practiceJ Int Med Res19922021621701521672
  • SchenckCHMahowaldMWLong-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adultsAm J Med199610033333378629680
  • Ancoli-IsraelSRichardsonGSManganoRMJenkinsLHallPJonesWSLong-term use of sedative hypnotics in older patients with insomniaSleep Med20056210711315716214
  • KrystalADWalshJKLaskaESustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomniaSleep200326779379914655910
  • JacobsGDIs eszopiclone appropriate and effective for the long-term clinical management of insomniaSleep200427234515124733
  • MorinCMBastienCHBrinkDBrownTRAdverse effects of temazepam in older adults with chronic insomniaHum Psychopharmacol2003181758212532318
  • RegesteinQRReichPA sleep clinic within a general hospital psychiatry serviceGen Hosp Psychiatry1980221121177390146
  • GillinJCByerleyWFDrug therapy: the diagnosis and management of insomniaN Engl J Med199032242392482242104
  • TerzanoMGRossiMPalombaVSmerieriAParrinoLNew drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplonDrugs2003264261282
  • ShahRUrenZBakerAMajeedADeaths from antidepressants in England and Wales 1993–1997: analysis of a new national databasePsychol Med20013171203121011681546
  • BolsterMCurranJBusuttilAA five year review of fatal self-ingested overdoses involving amitriptyline in Edinburgh 1983–1987Hum Exp Toxicol199413129318198826
  • HenryJAAlexanderCASenerEKRelative mortality from overdose of antidepressantsBMJ199531069742212247866123
  • ShapiroCMParryMRIs unemployment a cause of ParasuicideBr Med J (Clin Res Ed)198428964581622
  • KripkeDFKlauberMRWingardDLFellRLAssmusJDGarfinkelLMortality hazard associated with prescription hypnoticsBiol Psychiatry19984396876939583003
  • KripkeDFChronic hypnotic use: deadly risks, doubtful benefitSleep Med Rev20004152012531158
  • BliwiseDLTreating insomnia: pharmacological and tnonpharmacological approachesJ Psychoactive Drugs19912343353411813605
  • ShapiroCMMacFarlaneJGMacLeanAWAlleviating sleep-related discontinuance symptoms associated with benzodiazepine withdrawal: a new approachJ Psychosom Res199337Suppl 155578445587
  • ShapiroCMOhayonMMEbrahimIGrunsteinRFighting Fatigue and SleepinessThornhill, ONJoli Joco Publications, Inc.2005
  • HajakGGeislerPExperience with zolpidem ‘as needed’ in primary care settingsCNS Drugs200418Suppl 1354015291012
  • VallieresAMorinCMGuayBBastienCHLeBlancMSequential treatment for chronic insomnia: a pilot studyBehav Sleep Med2004229411215600227
  • MorinCMCognitive-behavioral approaches to the treatment of insomniaJ Clin Psychiatry200465Suppl 16334015575803
  • MorinCMBelangerLBastienCVallieresALong-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapseBehav Res Ther200543111415531349
  • MorinCMVallieresAGuayBCognitive behavioral therapy, singly and combined with medication, for persistent insomnia. A randomized controlled trialJAMA2009301192005201519454639
  • ShapiroCMShermanDPeckDFWithdrawal from benzodiazepines by initially switching to zopicloneEur Psychiatry199510Suppl 3145S151S19698411
  • ShapiroCZopiclone as a catalyst to hypnotic withdrawalJoyceDPartinenMRothTRutherEZopiclone: From Clinical Practice to Quality of LifeCopenhagen, DenmarkAEP199431
  • LemoinePOhayonMMIs hypnotic withdrawal facilitated by the transitory use of a substitute drug?Prog Neuropsychopharmacol Biol Psychiatry19972111111249075261
  • KushidaCALittnerMRMorgenthalerTPractice parameters for the indications for polysomnography and related procedures: an update for 2005Sleep200528449952116171294
  • HauriPJOlmsteadEMReverse first night effect in insomniaSleep1989122971052711096
  • BackhausJJunghannsKBroocksARiemannDHohagenFTest-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomniaJ Psychosom Res200253373774012217446
  • ChessonAJrHartseKAndersonWMPractice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep MedicineSleep200023223724110737341
  • Ancoli-IsraelSColeRAlessiCChambersMMoorcroftWPollakCPThe role of actigraphy in the study of sleep and circadian rhythmsSleep200326334239212749557
  • MorgenthalerTAlessiCFriedmanLPractice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007Sleep200730451952917520797
  • SoldatosCRDikeosDGPaparrigopoulosTJThe diagnostic validity of the Athens Insomnia ScaleJ Psychosom Res200355326326712932801
  • BuysseDJReynoldsCF3rdMonkTHBermanSRKupferDJThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchPsychiatry Res19892821932132748771
  • ShapiroCMFlaniganMFlemingJADevelopment of an adjective checklist to measure five FACES of fatigue and sleepiness. Data from a national survey of insomniacsJ Psychosom Res200252646747312069871
  • KruppLBLaRoccaNGMuir-NashJSteinbergADThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosusArch Neurol19894610112111232803071
  • LégerDPartinenMHirshkowitzMChokrovertySHednerJEQUINOX (Evaluation of daytime QUality Impairment by Nocturnal awakenings in Outpatient’s eXperience) Survey InvestigatorsCharacteristics of insomnia in a primary care setting: EQUINOX survey of 5293 insomniacs from 10 countriesSleep Med2010111098799821093363
  • LiebermanJAUpdate on the safety considerations in the management of insomnia with hypnotics: incorporating modified release formulations into primary careJ Clin Psychiatry2007912531
  • RoehrsTRothT‘Hypnotic’ prescription patterns in a large managed-care populationSleep Med20045546346615341891
  • VirkSSchwartzTLJindalSNihalaniNJonesNPsychiatric medication induced obesity: an aetiologic reviewObes Rev20045316717015245385
  • FabianTJAmicoJAKrobothPDParoxetine-induced hyponatremia in older adults: a 12-week prospective studyArch Intern Med2004164332733214769630
  • BiswasPNWiltonLVShakirSAThe pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in EnglandJ Psychopharmacol200317112112612680749
  • LubyEDSingareddyRKLong-term therapy with lithium in a private practice clinic: a naturalistic studyBipolar Disord200351626812656941
  • National Institutes of HealthNational Institute of Health Sate of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005Sleep20052891049105716268373